Steven Paul Damon is an accomplished inventor based in Johns Creek, GA (US). He has made significant contributions to the field of transdermal delivery systems, particularly focusing on abuse and misuse deterrent technologies. With a total of 3 patents, his work addresses critical issues in drug safety and efficacy.

Latest Patents

One of his latest patents is for an abuse and misuse deterrent transdermal system. This innovative patch incorporates aversive agents within its backing layer. The aversive agents are designed to exhibit biphasic or sustained kinetics of release. An immediate portion is released rapidly, while an extended portion is released in a prolonged manner when exposed to a dissolution medium. This prolonged release mechanism provides deterrence against the extraction of drugs from both fresh and used patches. It also serves to prevent accidental misuse of used patches by children. The patch systems can be utilized for the transdermal delivery of therapeutically active agents, particularly those drugs that are highly prone to abuse, such as opiate and opioid analgesics and stimulants.

Career Highlights

Throughout his career, Steven has worked with notable companies, including Nutriband, Inc. and 4P Therapeutics. His expertise in developing innovative drug delivery systems has positioned him as a key figure in the industry.

Collaborations

Steven has collaborated with several professionals in his field, including David James Enscore and Frank Tagliaferri. These collaborations have further enhanced his contributions to the development of advanced transdermal systems.

Conclusion

Steven Paul Damon is a pioneering inventor whose work in abuse and misuse deterrent transdermal systems has the potential to significantly impact drug safety. His innovative approaches continue to address critical challenges in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.